Detailed Mechanism Funding and Narrative

Years of mechanism: 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 1
Country/Region: Zimbabwe
Year: 2006
Main Partner: Not Available
Main Partner Program: NA
Organizational Type: Unknown
Funding Agency: Redacted
Total Funding: $19,539,183

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Care: Adult Care and Support (HBHC): $1,144,458

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Care: Orphans and Vulnerable Children (HKID): $1,670,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Laboratory Infrastructure (HLAB): $725,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Treatment: ARV Drugs (HTXD): $900,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Treatment: Adult Treatment (HTXS): $2,919,750

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Sexual Prevention: Abstinence/Be Faithful (HVAB): $2,556,733

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Testing: HIV Testing and Counseling (HVCT): $2,285,137

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Sexual Prevention: Other Sexual Prevention (HVOP): $997,842

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Strategic Information (HVSI): $861,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Care: TB/HIV (HVTB): $75,000

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT): $2,334,250

Mechanism and partner data have not been released by PEPFAR at this time.

Funding for Health Systems Strengthening (OHSS): $3,070,013

Mechanism and partner data have not been released by PEPFAR at this time.